Citizens Maintains Market Outperform on Exelixis, Raises Price Target to $65
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsPrice Target
Citizens analyst Silvan Turkcan maintains Exelixis (NASDAQ:EXEL) with a Market Outperform and raises the price target from $55 to $65.
Citizens analyst Silvan Turkcan maintains Exelixis (NASDAQ:EXEL) with a Market Outperform and raises the price target from $55 to $65.